A sex-specific platelet switch controls anti-tumor immunity in glioblastoma
Cancer Cell · 2026-11 · 44 (11) · 2173-2188.e13
DOI: 10.1016/j.ccell.2026.10.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Anthony R Sloan und 46 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA; Case Comprehensive Cancer Center, Cleveland, OH…. Hauptthemen laut MEDLINE: Glioblastoma, Blood Platelets, Receptors, Thrombin, Brain Neoplasms. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Sex differences in glioblastoma (GBM) outcomes are shaped by biological, hormonal, and immune factors, but the mechanisms driving these disparities remain unclear. We identify platelet protease-activated receptor 4 (PAR4) signaling as a regulator of sex-specific anti-tumor immunity. GBM patients exhibit increased platelet reactivity driven by PAR4. In murine models, pharmacologic or genetic inhibition of PAR4 prolongs survival in females, but not males, and is estrogen dependent, persisting in hormonal females regardless of chromosomal sex. The survival advantage is mediated within the tumor microenvironment through enhanced CD8+ T cell infiltration and function. PAR4-activated platelets suppress CD8+ T cell activity, whereas CD8+ T cell depletion abolishes both tumor-induced platelet reactivity and the PAR4-dependent survival advantage. Mechanistically, PAR4 inhibition enhances CD8+ T cell signaling through interaction with estrogen receptor β (ERβ). These findings demonstrate that platelets are critical regulators of sex-specific anti-tumor immunity and identify PAR4 as a promising therapeutic target in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA; Case Comprehensive Cancer Center, Cleveland, OH 44106, USA.
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA; Case Comprehensive Cancer Center, Cleveland, OH 44106, USA; Cleveland Clinic Lerner College of Medicine of Case Weste…
- Department of Heart, Blood, and Kidney Research, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.
- Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA; NIH Oxford-Cambridge Scholars Program, National Ins…
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA; Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, Natio…
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- National Institutes of Health National Cancer Institute
- National Heart Lung and Blood Institute
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Sloan, A. R., Bukenya, G., Tannish, G. P., Silver, D. J., Aggarwal, A., Lee, J., Rosoff, D., Alban, T. J., Juric, I., Parsai, S., Baruah, V., Bodovetz, T., Whitfield, D., Tack, L., Navadgi, T., Reitz, N., Ho, S. T., Badani, A., Goldberg, J., …, & Lathia, J. D. (2026). A sex-specific platelet switch controls anti-tumor immunity in glioblastoma. Cancer Cell, 44(11), 2173-2188.e13. https://doi.org/10.1016/j.ccell.2026.10.004
Vancouver
Sloan AR, Bukenya G, Tannish GP, Silver DJ, Aggarwal A, Lee J, et al. A sex-specific platelet switch controls anti-tumor immunity in glioblastoma. Cancer Cell. 2026;44(11):2173-2188.e13. doi:10.1016/j.ccell.2026.10.004
BibTeX
@article{Sloan2026,
author = {Sloan, Anthony R and Bukenya, George and Tannish, Gavin P and Silver, Daniel J and Aggarwal, Anu and Lee, Juyeun and Rosoff, Daniel and Alban, Tyler J and Juric, Ivan and Parsai, Shikha and Baruah, Vargab and Bodovetz, Tyler and Whitfield, Donovan and Tack, Liza and Navadgi, Tanvi and Reitz, Natalie and Ho, Shawn T and Badani, Aarav and Goldberg, Jessica and Yuan, Xueer and Gaboriau, Aymerick and Kamatala, Samrutha and Coker, Jesse and Kumar, Vrishabhadev Sathish and Jain, Saachi S and Xu, Chang and Scalise, Alliefair and Rajasekar, Bhairavi and Vincenti, Alex and Mulkearns-Hubert, Erin E and Horbinski, Craig M and Sloan, Andrew E and Hubert, Christopher G and Luo, Jingqin and Rubin, Joshua B and Stavrou, Evi X and Lohoff, Falk W and Goodman, Wendy A and Miller, Tyler E and O'Connor, Christine M and Nieman, Marvin T and Sangwan, Naseer and Chan, Timothy A and Khorana, Alok A and Dhawan, Andrew and Cameron, Scott J and Lathia, Justin D},
title = {A sex-specific platelet switch controls anti-tumor immunity in glioblastoma},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2173--2188.e13},
doi = {10.1016/j.ccell.2026.10.004}
}
EUVIMED